Dr. Pang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
# Grant
Stanford, CA 94305Phone+1 650-723-6661Fax+1 650-498-6205
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2014 - 2018- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2012 - 2014
Stanford University School of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2013 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Pharmacokinetics of Briquilimab as a Conditioning Agent for Hematopoietic Stem Cell Transplantation in Patients With Severe Combined Immunodeficiency, Myelodysplastic ...Dawoon Jung, Janel R Long-Boyle, Wendy W Pang, Jogarao V S Gobburu
Transplantation and Cellular Therapy. 2024-09-01 - 4 citations5-Azacytidine depletes HSCs and synergizes with an anti-CD117 antibody to augment donor engraftment in immunocompetent mice.Andriyana K Bankova, Wendy W. Pang, Brenda J. Velasco, Janel Long-Boyle, Judith A. Shizuru
Blood Advances. 2021-10-12 - 13 citationsRUNX3 levels in human hematopoietic progenitors are regulated by aging and dictate erythroid-myeloid balance.Peter Balogh, Emmalee R. Adelman, John V. Pluvinage, Brian J. Capaldo, Katie Freeman
Haematologica. 2020-04-01
Press Mentions
Jasper Therapeutics Initiates New Clinical Trial with National Cancer Institute to Evaluate JSP191 in GATA2-Related Myelodysplastic SyndromesSeptember 8th, 2021- Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia Undergoing Hematopoietic Cell TransplantationFebruary 8th, 2021
Antibody Could Increase Cure Rate for Blood, Immune DisordersFebruary 11th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
